Literature DB >> 1368797

Relationship between hybridoma growth and monoclonal antibody production.

P M Hayter1, N F Kirkby, R E Spier.   

Abstract

Factors affecting cell growth and antibody production in a mouse hybridoma were investigated. Antibody was produced during the growth and decline phases of a batch culture with an increase in the specific rate of antibody production during the decline phase. The specific rate of antibody production was also increased in cells arrested by 2 mM thymidine, suggesting that cell proliferation and antibody production can be uncoupled. Reduced serum concentrations resulted in lower cell growth rates but increased antibody production rates. However, this trend was reversed in hybridomas which had been arrested by thymidine, since the highest antibody production rate was associated with high serum concentrations. Likewise, in proliferating cells, the optimum pH for antibody production (pH 6.8) was lower than the optimum pH for cell growth (pH 7.2), whereas in thymidine-blocked cells, the highest antibody production rate was at pH 7.2. High antibody production rates and product yields were also associated with low growth rates in continuous cultures. The possibility that antibody was under cell cycle control was investigated in synchronized hybridoma cultures. Antibody production occurred during G1 and G2 with a decline in the M phase and evidence of a further decline in the S phase. Thus antibody production was not restricted to the G1 and S phase in this hybridoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1368797     DOI: 10.1016/0141-0229(92)90137-d

Source DB:  PubMed          Journal:  Enzyme Microb Technol        ISSN: 0141-0229            Impact factor:   3.493


  10 in total

1.  Descriptive parameter evaluation in mammalian cell culture.

Authors:  R L Dutton; J M Scharer; M Moo-Young
Journal:  Cytotechnology       Date:  1998-03       Impact factor: 2.058

2.  Long-term Continuous Production of Monoclonal Antibody by Hybridoma Cells Immobilized in a Fibrous-Bed Bioreactor.

Authors:  Hui Zhu; Shang-Tian Yang
Journal:  Cytotechnology       Date:  2004-01       Impact factor: 2.058

3.  Techniques for dual staining of DNA and intracellular immunoglobulins in murine hybridoma cells: applications to cell-cycle analysis of hyperosmotic cultures.

Authors:  Kathleen M McNeeley; Zhe Sun; Susan T Sharfstein
Journal:  Cytotechnology       Date:  2005-06       Impact factor: 2.058

4.  A novel method for monitoring monoclonal antibody production during cell culture.

Authors:  Henryk Szmacinski; Derek S Smith; Michael A Hanson; Yordan Kostov; Joseph R Lakowicz; Govind Rao
Journal:  Biotechnol Bioeng       Date:  2008-06-15       Impact factor: 4.530

5.  Substitution of transferrin by FeCl3 in the development of a low foetal calf serum concentration medium for KB-26.5 hybridoma cell line.

Authors:  B Damgaard; A Sanfeliu; J J Cairó; C Casas; C Solà; F Gòdia
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

6.  Effects of hydroxyurea on monoclonal antibody production induced by anti-mIgG and LPS stimulation on murine B cell hybridomas.

Authors:  Alicia Martín-López; Asterio Sánchez-Mirón; Francisco García-Camacho; Antonio Contreras-Gómez; Emilio Molina-Grima
Journal:  Cytotechnology       Date:  2010-05-21       Impact factor: 2.058

7.  Production of immunoglobulin A in different reactor configurations.

Authors:  T Stoll; C Perregaux; U von Stockar; I W Marison
Journal:  Cytotechnology       Date:  1995-02       Impact factor: 2.058

8.  Effects of organic pH buffers on a cell growth and an antibody production of human-human hybridoma HB4C5 cells in a serum-free culture.

Authors:  K Nagira; M Hayashida; M Shiga; K Sasamoto; K Kina; K Osada; T Sugahara; H Murakami
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

9.  Effect of feed rate on growth rate and antibody production in the fed-batch culture of murine hybridoma cells.

Authors:  J D Jang; J P Barford
Journal:  Cytotechnology       Date:  2000-03       Impact factor: 2.058

10.  The effect of the catalytic topoisomerase II inhibitor dexrazoxane (ICRF-187) on CC9C10 hybridoma viability and productivity.

Authors:  N Barnabé; M Butler; B B Hasinoff
Journal:  Cytotechnology       Date:  2001-10       Impact factor: 2.058

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.